← Back
Data updated: Jun 28, 2026
GRAHAM DM
Generics Pharmaceuticals
GRAHAM DM is a generic drug manufacturer with 6 FDA-approved products.
1981
Since
6
Drugs
-
Trials
0
New Drugs (2yr)
Modality:
GRAHAM DM's Key Drugs
GRAHAM DM's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
No active drugs
GRAHAM DM's Recent FDA Approvals
New NDA/BLA approvals for GRAHAM DM over the last two years — novel drugs only, excluding generics and label supplements.
No recent approvals
GRAHAM DM's Therapeutic Areas
Disease areas where GRAHAM DM has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
GRAHAM DM Pipeline Snapshot
Active clinical trials for GRAHAM DM across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1981-09-17
- Latest
- 1997-06-25
- Applications
- 18